AnthelosLatest News

Up to date information on our latest breakthroughs and developments.
bt_bb_section_bottom_section_coverage_image
https://anthelos.com/wp-content/uploads/2021/07/aksci.png

Anthelos widened its chemical portfolio with AK Scientific Inc. (Union City, California, USA) (www.aksci.com) after taking over the Hungarian distibutorship from Avidin (www.avidinbiotech.com) in June, 2021. AKSci provides high quality Inhibitors, Modulators, Ligands, Bioactives, and Reference Compounds for life science research, drug discovery, and many other research & development needs. Novel Building Blocks, Intermediates, and...

https://anthelos.com/wp-content/uploads/2021/07/moldiag_resized-1280x640.png

Anthelos has developed a novel molecular diagnostic product, the Microbiome genomic analysis kit (Cat. no. Ant-08) enabling semiquantitative detection of bacteria and fungi from diverse biological and environmental samples. The kit includes well designed primer sets that amplify 2 bacterial and 2 fungal genomic regions. The amplified products can be further analyzed by cloning, traditional...

https://anthelos.com/wp-content/uploads/2021/07/targetmol_resized.png

Anthelos is proud to anounce that from January 2021 the company became the local distributor of TargetMol company (www.targetmol.com) in Hungary. With the expertise of Anthelos chemists we offer full support for our customers from both the academic and biotech sectors. Anthelos arranges shipment, customs clearance and all administration with fast delivery of the ordered...

https://anthelos.com/wp-content/uploads/2021/01/output-onlinepngtools-7-1280x640.png

Within the first few weeks after Anthelos foundation, our team of specialists validated a real-time Reverse Transcriptase PCR (QPCR) assay for the specific detection of the SARS-CoV-2 virus using saliva, sputum and nasal swabs. We used our know-how to establish the Inf-Cov2QuantTM Influenza A/B + SARS-CoV-2 Quantification Kit (ICQ-100), which is a multiplex molecular in vitro...